Artivion, INC Form 4 insider transactions

Marshall Stanton, SVP of Clinical & MD Affairs at Artivion, Inc., files an amendment to a previous SEC Form 4 to correct the number of shares sold to cover tax withholding obligations.

Rochelle L. Maney, VP of Quality at Artivion Inc., filed an amended Form 4 with the SEC to correct the number of shares sold to cover tax withholding obligations.

Jean F. Holloway, SVP and General Counsel of Artivion, Inc., files an amended Form 4 to correct the number of shares sold to cover tax withholding obligations.

Andrew M. Green, VP of Regulatory at Artivion Inc., filed an amended SEC Form 4/A to correct errors in the number of shares sold to cover tax withholding obligations upon the vesting of performance stock units.

John E. Davis, Chief Commercial Officer of Artivion, Inc., files an amended Form 4 to correct the number of shares sold to cover tax withholding obligations upon the vesting of performance stock units.

Marshall S. Stanton, SVP of Clinical & MD Affairs at Artivion, Inc., filed an amendment to his Form 4 to correct the number of shares beneficially owned following a sell-to-cover transaction.

Rochelle L. Maney, VP of Quality at Artivion, Inc., amends a previous SEC filing to correct the number of shares beneficially owned following a sell-to-cover transaction.

Andrew M. Green, VP of Regulatory at Artivion, Inc., files an amendment to a previous Form 4 to correct the number of shares beneficially owned following a sale to cover tax withholding obligations.

Amy Horton, VP and Chief Accounting Officer of Artivion, Inc., filed an amendment to a previous SEC Form 4 to correct the number of shares beneficially owned following a sell-to-cover transaction.

Chief Commercial Officer of Artivion, John E. Davis, files an amendment to his Form 4, correcting the number of shares beneficially owned following a sell-to-cover transaction.

Artivion's CEO, James P. Mackin, filed an amended SEC Form 4/A to correct administrative errors in the number of shares sold to cover tax withholding obligations upon the vesting of performance stock units.

Jean F. Holloway, SVP and General Counsel of Artivion, Inc., filed an amendment to a previous SEC Form 4 to correct the number of shares beneficially owned following a sell-to-cover transaction.

Amy Horton, VP and Chief Accounting Officer of Artivion, Inc., files an amended Form 4 detailing changes in beneficial ownership due to LTIP performance stock units vesting and subsequent sale of shares to cover tax obligations.

Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., filed an amendment to his Form 4, reporting the acquisition and disposition of common stock on March 1, 2024, due to the vesting of performance stock units and a correction of a previous reporting error.

Matthew Getz, VP of Human Resources at Artivion, Inc., files an amended SEC Form 4/A to correct the number of shares sold to cover tax withholding obligations.

Matthew A. Getz, VP of Human Resources at Artivion, Inc., files an amendment to a previous Form 4 to correct the number of shares beneficially owned following a sell-to-cover transaction.

Rochelle L. Maney, VP of Quality at Artivion, Inc., filed an amended Form 4 with the SEC to correct the number of shares beneficially owned following a previous reporting error related to sell-to-cover transactions.

James P. Mackin, CEO of Artivion, Inc., files an amendment to a previous SEC Form 4 to correct the number of shares beneficially owned following a sell-to-cover transaction.

Jean F. Holloway, SVP and General Counsel of Artivion, Inc., filed an amendment to a previous Form 4, reporting changes in beneficial ownership of company stock due to LTIP performance stock units and sales to cover tax obligations.

Artivion's VP of Regulatory, Andrew M. Green, files an amended Form 4 detailing changes in beneficial ownership due to the issuance of LTIP performance stock units and a sale of shares to cover tax obligations.

Matthew Getz, VP of Human Resources at Artivion, Inc., files an amended Form 4 detailing stock transactions, including the acquisition of performance stock units and a sale to cover tax obligations.

John E. Davis, Chief Commercial Officer of Artivion, Inc., files an amended SEC Form 4 to correct the number of shares beneficially owned following a previous reporting error and recent transactions involving performance stock units.

Artivion's CEO, James P. Mackin, files an amendment to a previous SEC Form 4 to correct the number of shares beneficially owned following the vesting of performance stock units and subsequent sell-to-cover transactions.

Artivion's CEO, James P. Mackin, reports acquisition of shares through LTIP performance stock units and subsequent sale to cover tax obligations.

Jean F. Holloway, SVP and General Counsel of Artivion, Inc., reports acquisition and disposal of company stock related to LTIP performance stock units.

Chief Commercial Officer of Artivion, Inc., John E. Davis, reports acquisition and disposal of company stock related to performance stock units.

Matthew A. Getz, VP of Human Resources at Artivion, Inc., reports the acquisition and disposal of company stock, including shares sold to cover tax obligations.

Rochelle L. Maney, VP of Quality at Artivion, Inc., reports acquisition of performance stock units and sale of shares to cover tax obligations.

Andrew Green, VP Regulatory at Artivion, Inc., reports acquisition and disposal of common stock related to LTIP performance stock units.

Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., reports acquisition of 5,724 shares and disposition of 1,506 shares of common stock.